Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
Our core peptide discovery platform is called Peptide Information Compression Technology (PICT), which consists of a diverse peptide library named ZSenithFive®, containing information on nearly half-billion peptides. The PICT platform is ideal for the discovery of functionally active peptides directly from cell-based and biochemical high-throughput screening (HTS) assays. In addition, we have developed 4 complimentary peptide discovery platforms: the Disulfide-rich Peptide Phage Display (DRP-PD) platform, the Animal Toxin Peptide Library Platform, the Nano-Cyclic Peptide Library Platform, and the Virtual Peptide Library Platform.
PepLib successfully raised 100 million yuan (USD 16 million) in Series Pre-A financing in 2019 and secured Series A financing of 220 million yuan (USD 35 million) in 2021. PepLib has been working towards Series Pre-IPO financing since March 2022. PepLib has more than 190 employees, and more than 80% of the workforce is made up of R&D personnel.
At PepLib, our main therapeutic area focus is oncology and cardiometabolic diseases, where oncology programs are driven by the development of peptide drug conjugates (PDCs) and peptide radionuclide conjugates (PRCs).
Company Details
- Employees
- 6
- Founded
- -
- Address
- Building 5, 1769 Yunlong Blvd., Shifeng District, Zhuzhou,hunan 412000,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.peplib.com
- HQ
- Zhuzhou, Hunan
Peplib Questions
Peplib's website is http://www.peplib.com
Peplib's LinkedIn profile is https://www.linkedin.com/company/zonsen-peplib-biotech
Peplib has
6 employees.
View email and phone details for 6
employees at Peplib.
Peplib's industry is
Biotechnology Research
Peplib's top competitors are
Hengrui Pharma,
Innovent Biologics,
Regeneron,
Sinoway Industrial Co., Ltd.,
Eli Lilly And Company,
Vc-Backed Biotech Newco,
Gensci,
Sri,
Highlight Capital.
Peplib's categories are Biotechnology Research
Peplib's founding year is 2017
